KALLYOPE

Owners

Goods & Services

pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability ; pharmaceutical preparations and substances for treatment of diseases related to the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules

Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability; biochemicals for in vitro and in vivo scientific or research use; ; Active chemical ingredients for scientific or research use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability

medical and scientific research in the fields of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability; scientific and medical research and development; biological research and development; bacteriological research and development; pharmaceutical scientific research and development; pharmaceutical new product research and development for others; scientific chemical, biochemical, biotechnological, biological and bacteriological research and analysis; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; medical and scientific research in the fields of diseases of the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules